AQR Capital Management
HRMY icon

AQR Capital Management’s Harmony Biosciences HRMY Stock Holding History

AQR Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34M Buy
934,326
+218,080
+30% +$6.88M 0.01% 957
2026
Q1 		$20.1M Sell
716,246
-97,643
-12% -$3.2M 0.01% 1031
2025
Q4 		$30.5M Buy
813,889
+458,321
+129% +$15.1M 0.02% 813
2025
Q3 		$9.8M Buy
355,568
+203,539
+134% +$7.01M 0.01% 1104
2025
Q2 		$4.8M Sell
152,029
-14,311
-9% -$460K ﹤0.01% 1309
2025
Q1 		$5.52M Buy
166,340
+7,484
+5% +$268K 0.01% 1087
2024
Q4 		$5.47M Buy
158,856
+16,271
+11% +$559K 0.01% 1060
2024
Q3 		$5.7M Sell
142,585
-11,760
-8% -$413K 0.01% 993
2024
Q2 		$4.66M Buy
154,345
+1,116
+0.7% +$33.6K 0.01% 1054
2024
Q1 		$5.15M Sell
153,229
-26,526
-15% -$851K 0.01% 974
2023
Q4 		$5.81M Buy
179,755
+11,236
+7% +$314K 0.01% 886
2023
Q3 		$5.52M Buy
168,519
+22,126
+15% +$768K 0.01% 876
2023
Q2 		$5.15M Buy
146,393
+92,843
+173% +$3.21M 0.01% 889
2023
Q1 		$1.75M Buy
53,550
+21,627
+68% +$985K ﹤0.01% 1311
2022
Q4 		$1.76M Sell
31,923
-1,453
-4% -$79.9K ﹤0.01% 1311
2022
Q3 		$1.48M Buy
33,376
+22,653
+211% +$1.1M ﹤0.01% 1337
2022
Q2 		$523K Buy
+10,723
New +$483K ﹤0.01% 1669

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management's HRMY Position: Q2 2026 in Review

AQR Capital Management increased its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, buying an estimated $6.88M and bringing the position to 934,326 shares worth $34M. The position accounts for 0.01% of the portfolio, ranked #957.

AQR Capital Management first reported a position in HRMY in Q2 2022 and has held it in 17 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • AQR Capital Management held 934,326 shares of Harmony Biosciences worth $34M as of Q2 2026.
  • AQR Capital Management bought 218,080 Harmony Biosciences shares in Q2 2026, an estimated $6.88M.
  • Harmony Biosciences made up 0.01% of AQR Capital Management's portfolio in Q2 2026, its #957 holding.
  • AQR Capital Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.